Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

Beta Bionics Inc.’s concept of an artificial pancreas that regulates blood sugar levels in people with type 1 diabetes (T1D) ...

Insulet Corporation (NASDAQ:PODD) showcases a high Return on Invested Capital (ROIC) of 16.28% and a Weighted Average Cost of ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

Despite consistent improvements in glycemic outcomes across simulations, real-world adoption is lagging. The study finds that ...

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

People who have diabetes will receive an opportunity to learn more about monitors, pumps and other devices during Columbus Community Hospital’s Spring Diabetes Technology Fair. The event will take ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former ...

Type 1 and type 2 diabetes require different approaches. Discover the 9 essential distinctions that affect daily management ...